Jeff Sorenson and Gael Kuhn, Co-founders, Yunu, discuss adapting to the specific needs and considerations of trials with cardiac, neuro, and pulmonary specialties.
ACT: How does your platform adapt to the specific needs and considerations of trials with cardiac, neuro, and pulmonary specialties compared to oncology trials?
Sorenson: The unit platform supports all formats of imaging data. The workflows are really the same, whether it's an oncology trial or a trial in another specialty area. So, we're not just specific to oncology. A cardiac trial, for example, can be set up that runs across any of the chosen sites that are already set up on the platform. For example, you can set up additional cardiac specific sites in cardiology practices. Each trial is configured on our platform independently. So, it doesn't matter that those sites are using our platform for oncology clinical trials, you can separately and independently use our platform simultaneously for cardiology, or pulmonology, or gastroenterology trials. When you look at the requirements for that, the things that they need to do is collect data, QC the data, take the measurements, have a physician sign off, and send the data to the study staff and to downstream systems, all of which are supported in our platform today. We're always adding new capabilities to support new modalities, different volumetric use cases, and allow sponsors more control and more visibility over their imaging trials across the entire range of work that they perform in their clinical trials operations.
ACT: Decentralized clinical trials are increasingly important, but imaging can be a major hurdle. How does Yunu facilitate efficient and reliable imaging within a decentralized trial setting?
Kuhn: Yunu is a collaborative ecosystem where the patient scan can be captured in any location. The treating physician being in one place, the treating oncologist in another, and the reading radiologist in yet another with everything synchronized in a single workflow. Also, communication is especially important within decentralized workflow. Yunu provides closed loop workflow with communication that will occur within the platform so everything runs faster.
Funding Cuts Threaten Diversity in Clinical Research
June 27th 2025In this video interview, Kyle McAllister, co-founder, CEO, Trially, discusses how recent federal funding cuts are likely to undermine research focused on underrepresented populations, and why long-term investment in community-based studies is essential to closing persistent health equity gaps.
2025 DIA Annual Meeting: Why AI and Automation Are Set to Become the New Normal in Clinical Research
June 20th 2025Peter Ronco, CEO, Emmes, shares his long-term vision for artificial intelligence in clinical research, from making automation routine to improving drug discovery, transforming regulatory oversight, reducing animal testing, and promoting ethical, equitable data use worldwide.
SCOPE Summit 2025: Enhancing the Patient Experience Through Site Centricity
February 12th 2025In an interview with ACT senior editor Andy Studna at SCOPE Summit, Ashley Davidson, vice president, product lead - sponsor tech strategy, Advarra, highlights the need for more site-centric approaches in study startup.